Related Experiment Video
Updated: May 1, 2026

Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Concordance with recommended postdischarge care guidelines among children with food-induced anaphylaxis
Pamela B Landsman-Blumberg1, Wenhui Wei2, Damon Douglas3
1Truven Health Analytics, Bethesda, MD.
Insights
Most children with food-induced anaphylaxis received epinephrine autoinjector (EAI) prescriptions post-discharge, but fewer saw specialists. Repeat anaphylaxis events were uncommon, suggesting a need to improve adherence to recommended care guidelines.
Area of Science:
- Pediatric Allergy and Immunology
- Emergency Medicine
- Health Services Research
Background:
- Food-induced anaphylaxis is a significant concern in pediatric emergency care.
- Post-discharge care adherence is crucial for preventing recurrent severe allergic reactions.
Purpose of the Study:
- To evaluate patient characteristics, adherence to recommended post-discharge care, and the incidence of recurrent anaphylaxis in US children.
- To analyze the rates of epinephrine autoinjector (EAI) prescription fills and specialist visits within one year of discharge.
Main Methods:
- Retrospective analysis of 1009 children (<18 years) hospitalized or seen in the ED for food-induced anaphylaxis (2002-2008).
- Utilized Truven Health MarketScan databases with continuous insurance coverage for at least one year pre- and post-index event.
- Assessed 1-year post-discharge rates of EAI fills, allergist/immunologist visits, and repeat anaphylaxis events.
Main Results:
- The cohort averaged 7 years old, with 58% males; 90% were discharged from the ED.
- Within one year, 83% received an EAI prescription (69% within a week), and 43% saw a specialist (51% within 4 weeks).
- A low rate of recurrent anaphylaxis (6.4%) was observed, with subsequent ED visits/hospitalizations for anaphylaxis being infrequent.
Conclusions:
- Adherence to EAI prescription fills was higher than for specialist visits among children treated for food-induced anaphylaxis.
- While repeat anaphylaxis events were infrequent, gaps exist between recommended care and actual patient/physician behaviors.
- Further research is needed to understand barriers to care adherence and its impact on outcomes and costs.
Objective:
To describe patient characteristics, concordance with recommended postdischarge care, and risk of repeat events within a cohort of children discharged from an emergency department (ED) or hospital for food-induced anaphylaxis in the US.
Study Design:
Children (aged <18 years) with an ED visit/hospitalization for food-induced anaphylaxis were identified from the 2002-2008 Truven Health MarketScan databases using an expanded International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code algorithm. The initial identified ED visit/hospitalization was the index event. Claims data for the children with continuous medical and prescription coverage for ≥1 year before and after the index event were evaluated. Analyses included the rates of 1-year postdischarge epinephrine autoinjector (EAI) prescription fills, allergist/immunologist visits, and repeat events.
Results:
The study cohort comprised 1009 patients with an average age of 7 years, including 58% males, 27% with a history of asthma, and 90% discharged from an ED. Within 1 year postdischarge, 83% had an EAI prescription fill (69% within 1 week postdischarge), 43% had a specialist visit (51% within 4 weeks postdischarge), and 6.4% had evidence of another anaphylaxis-related ED visit/hospitalization.
Conclusion:
Among children with food-induced anaphylaxis, within 1 year postdischarge from the ED or hospital, concordance was higher for EAI prescription fills than for allergist/immunologist visits. Subsequent ED visits/hospital stays for anaphylactic events were low. More research is needed to identify barriers between recommendations and physician/patient behaviors, as well as the impact of not following the recommendations on patient outcomes and healthcare costs.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Allergic Drug Reactions
Drug Dosing: Infants and Children
Tonsillitis II: Management
Asthma-IV: Nursing Management
First, in...

